Post Hoc Biomarker Analyses from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus

Askanase, A. D., Wright, D., Zhao, E., Zhu, J., Bilyk, R., & Furie, R. A. (2021). Post Hoc Biomarker Analyses from a Phase 4, Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of Repository Corticotropin Injection (Acthar® Gel) for Persistently Active Systemic Lupus Erythematosus. Rheumatology and Therapy, 8(4), 1871–1886. https://doi.org/10.1007/s40744-021-00351-7
Authors:
Anca D. Askanase
Dale Wright
Enxu Zhao
Julie Zhu
Roman Bilyk
Richard A. Furie
Affiliated Authors:
Anca D. Askanase
Columbia Affiliation:
Subjects:
Systemic Lupus Erythematosus and Antiphospholipid Syndrome (OpenAlex Topic)
Guillain-Barré Syndrome and Related Neuropathies (OpenAlex Topic)
Therapeutic Antibodies: Development, Engineering, and Applications (OpenAlex Topic)
Author Keywords:
autoimmune disease
glucocorticoid
acthar gel
repository corticotropin injection
systemic lupus erythematosus
biomarker
cytokine
immune cell
elink
Publication Type:
Article
Unique ID:
10.1007/s40744-021-00351-7
DOI:
10.1007/s40744-021-00351-7
Journal:
Rheumatology and Therapy
Publication Date:
Data Source:
Scopus
Source Link:
View Scopus Record
View PubMed Record
View Web of Science Record
View OpenAlex Record

Record Created: